<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7169770\results\search\testTrace\results.xml">
  <result pre="case notification rates at Chinese and international locations. The case" exact="detection" post="rate is changing daily and can be tracked in"/>
  <result pre="clinical sign of the SARSâ€�CoVâ€�2â€�related disease COVIDâ€�19 which allowed case" exact="detection" post="was pneumonia. More recent reports also describe gastrointestinal symptoms"/>
  <result pre="infected by SARSâ€�CoVâ€�2 who remain asymptomatic throughout the course of" exact="infection" post="has not yet been definitely assessed. In symptomatic patients,"/>
  <result pre="fatigue and other signs of upper respiratory tract infections. The" exact="infection" post="can progress to severe disease with dyspnoea and severe"/>
  <result pre="affected individuals every seven days and that each patient spreads" exact="infection" post="to 2.2 other individuals on average (R0) 6. Estimates"/>
  <result pre="or, if so, may show milder symptoms or even asymptomatic" exact="infection" post="7. As of 13. February 2020, the case fatality"/>
  <result pre="entry into the target cells 13. Baricitinib, used in the" exact="treatment" post="of rheumatoid arthritis, is an AAK1 and Janus kinase"/>
  <result pre="required for virusâ€�cell fusion, has the potential of blocking viral" exact="infection" post="15 and was shown to affect activation of p38"/>
  <result pre="several deadly virus infections and are being considered as potential" exact="treatment" post="candidates 18. Repurposing these available drugs for immediate use"/>
  <result pre="candidates 18. Repurposing these available drugs for immediate use in" exact="treatment" post="in SARSâ€�CoVâ€�2 infections could improve the currently available clinical"/>
  <result pre="8GuanW, NiZ, YuH, et al.Clinical characteristics of 2019 novel coronavirus" exact="infection" post="in China. medRxiv preprint posted online on Feb. 9,"/>
  <result pre="from: https://www.who.int/emergencies/mers-cov/en/.) 13RichardsonP, GriffinI, TuckerC et al. Baricitinib as potential" exact="treatment" post="for 2019â€�nCoV acute respiratory disease. Lancet2020S0140-6736(20)30304-4. 10.1016/S0140-6736(20)30304-4 14HolshueML, DeBoltC,"/>
  <result pre="TatsumiK, ImaiAM, SaitoK, KuriyamaT, ShirasawaH. Inhibition of human coronavirus 229E" exact="infection" post="in human epithelial lung cells (L132) by chloroquine: involvement"/>
  <result pre="Antiviral Res2008: 77: 150â€&quot;152.18055026 17ChuCM. Role of lopinavir/ritonavir in the" exact="treatment" post="of SARS: initial virological and clinical findings. Thorax2004: 59:"/>
 </snippets>
</snippetsTree>
